HURA · TuHURA Biosciences Inc
United States · RS rating 34 · As of 2026-11-03
| Price | 1.66 USD |
|---|---|
| 1-day change | -3.8% |
| RS rating (overall / 1M / 3M / 12M) | 34 / 33 / 30 / 28 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 20 / 28 / 28 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -7.7% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +47.5% |
| Market cap (USD) | $145.6M |